Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.14 EUR | -2.33% |
|
+3.21% | -7.69% |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.8 for the current period. Therefore, the company is undervalued.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.69% | 8.74B | - | ||
-12.14% | 1.31B | B+ | ||
-3.59% | 1.2B | - | ||
-30.41% | 748M | - | - | |
-.--% | 619M | - | - | |
+6.99% | 475M | - | ||
+2.38% | 433M | - | - | |
-34.41% | 294M | - | - | |
-63.28% | 265M | - | ||
+1.00% | 218M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.